Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 05/08/2026 | Q1 | $213.6M | -- | -- | $1.47 | -- |
| 02/27/2026 | Q4 | $231M | $247.1M | $1.17 | $1.98 | -$0.81 |
| 11/07/2025 | Q3 | $212.9M | $227.8M | $1.13 | $1.77 | -$0.64 |
| 08/08/2025 | Q2 | $190.1M | $211.4M | $0.36 | $1.42 | -$1.06 |
| 05/09/2025 | Q1 | $180.7M | $197.1M | $0.69 | $1.38 | -$0.70 |
| 02/28/2025 | Q4 | $175.4M | $190.6M | -$0.55 | $1.44 | -$1.98 |
| 11/08/2024 | Q3 | $144.4M | $148.3M | -$1.27 | $1.09 | -$2.35 |
| 08/06/2024 | Q2 | $129.1M | $138M | -$0.14 | $0.95 | -$1.09 |
| 05/10/2024 | Q1 | $126M | $137.4M | $0.83 | $1.00 | -$0.17 |
| 02/29/2024 | Q4 | $124.9M | $131.7M | $0.04 | $0.86 | -$0.82 |
| 11/08/2023 | Q3 | -- | $131.8M | $0.50 | -- | -- |
| 08/09/2023 | Q2 | -- | $116.5M | $0.33 | -- | -- |
| 05/08/2023 | Q1 | -- | $106.8M | $0.06 | -- | -- |
| 03/09/2023 | Q4 | -- | $94.2M | -$0.28 | -- | -- |
| 11/09/2022 | Q3 | -- | $83.8M | -$0.55 | -- | -- |
| 08/08/2022 | Q2 | -- | $73.9M | -$0.94 | -- | -- |
| 05/10/2022 | Q1 | -- | $64.5M | -$1.27 | -- | -- |
| 03/15/2022 | Q4 | -- | $60.9M | -$1.72 | -- | -- |
| 11/01/2021 | Q3 | -- | $52.1M | -$0.37 | -- | -- |
| 08/06/2021 | Q2 | -- | $48.6M | -$1.17 | -- | -- |
| 05/07/2021 | Q1 | -- | $54.5M | $0.01 | -- | -- |
| 03/09/2021 | Q4 | -- | $57.3M | -$0.30 | -- | -- |
| 11/05/2020 | Q3 | -- | $53M | $0.04 | -- | -- |
| 08/06/2020 | Q2 | -- | $48.5M | -$1.03 | -- | -- |
| 05/07/2020 | Q1 | -- | $49.8M | -$0.59 | -- | -- |
| 02/27/2020 | Q4 | -- | $48M | -$0.39 | -- | -- |
| 11/06/2019 | Q3 | -- | $51.3M | $0.32 | -- | -- |
| 08/07/2019 | Q2 | -- | $54.4M | $0.53 | -- | -- |
| 05/09/2019 | Q1 | -- | $52.9M | $0.04 | -- | -- |
| 02/27/2019 | Q4 | -- | $57.1M | $0.46 | -- | -- |
| 11/06/2018 | Q3 | -- | $50.7M | $0.42 | -- | -- |
| 08/07/2018 | Q2 | -- | $47.3M | $0.23 | -- | -- |
| 05/08/2018 | Q1 | -- | $46.5M | $0.19 | -- | -- |
| 02/27/2018 | Q4 | -- | $47.3M | -$0.83 | -- | -- |
| 11/02/2017 | Q3 | -- | $48.2M | $0.40 | -- | -- |
| 08/03/2017 | Q2 | -- | $44.8M | $0.23 | -- | -- |
| 05/04/2017 | Q1 | -- | $36.6M | $0.10 | -- | -- |
| 03/02/2017 | Q4 | -- | $38.2M | -$0.09 | -- | -- |
| 11/03/2016 | Q3 | -- | $38.5M | $0.22 | -- | -- |
| 08/04/2016 | Q2 | -- | $31.3M | $0.10 | -- | -- |
| 05/05/2016 | Q1 | -- | $20.6M | $0.12 | -- | -- |
ANI Pharmaceuticals, Inc. reported $247.1M worth of top line sales in its most recent quarter.
ANI Pharmaceuticals, Inc. announced earnings per share of $1.17 which represents a miss of analyst forecast a $1.98 per share.
ANI Pharmaceuticals, Inc. reported $124.2M that represents $5.70 per share over the last quarter.
ANI Pharmaceuticals, Inc.'s earnings are forecast to grow from $3.32 per share to $7.52 per share next year representing an increase of 172.5%.
ANI Pharmaceuticals, Inc.'s next earnings date is May 8, 2026.
Signup to receive the latest stock alerts
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Since January 28th, software stocks in the United States have…
Over the last five days, shares of Instagram and Facebook…
Market Cap: $4.5T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 34x
Market Cap: $3.7T
P/E Ratio: 28x
American Public Education, Inc. [APEI] is up 26.24% over the past day.
Papa John's International, Inc. [PZZA] is down 5.25% over the past day.
Nebius Group NV [NBIS] is up 0.87% over the past day.